China NT Pharma Group Company Limited (HKG:1011)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.670
+0.020 (3.08%)
Apr 29, 2026, 3:38 PM HKT
15.52%
Market Cap 635.83M
Revenue (ttm) 26.88M
Net Income (ttm) -28.98M
Shares Out 949.00M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 189,500
Average Volume 263,773
Open 0.660
Previous Close 0.650
Day's Range 0.660 - 0.690
52-Week Range 0.335 - 1.350
Beta -1.96
RSI 47.14
Earnings Date Mar 31, 2026

About HKG:1011

China NT Pharma Group Company Limited, an investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People’s Republic of China. It operates through Digital Services and Sales Agency Service segments. The company acts as agent for clients to sell medical and health-related products to external customers. It also provides marketing and promotion in relation to bone health knowledge. In addition, the company is involved in trading of prescription medicines... [Read more]

Sector Healthcare
Founded 1995
Employees 21
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1011
Full Company Profile

Financial Performance

In 2025, HKG:1011's revenue was 24.16 million, a decrease of -36.36% compared to the previous year's 37.96 million. Losses were -26.04 million, -51.19% less than in 2024.

Financial numbers in CNY Financial Statements

News

There is no news available yet.